Ashley Sharp
Overview
Explore the profile of Ashley Sharp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reeve L, Tessier E, Trindall A, Abdul Aziz N, Andrews N, Futschik M, et al.
Euro Surveill
. 2023 Sep;
28(39).
PMID: 37768561
We investigated an outbreak of SARS-CoV-2 variant BA.2.86 in an East of England care home. We identified 45 infections (33 residents, 12 staff), among 38 residents and 66 staff. Twenty-nine...
2.
Jain V, Sharp A, Neilson M, Bausch D, Beaney T
PLOS Glob Public Health
. 2023 Mar;
2(8):e0000246.
PMID: 36962712
The Joint External Evaluation (JEE) assesses national capacities to implement the International Health Regulations (IHR). Previous studies have found that higher JEE scores are associated with fewer communicable disease deaths....
3.
Guy R, Henderson K, Coelho J, Hughes H, Mason E, Gerver S, et al.
Euro Surveill
. 2023 Jan;
28(1).
PMID: 36695450
Increases in invasive group A streptococcal (iGAS) infection and associated deaths, particularly in children, above seasonally expected levels are being seen this season (772 notifications reported in weeks 37 to...
4.
Ladhani S, Guy R, Bhopal S, Brown C, Lamagni T, Sharp A
Lancet Child Adolesc Health
. 2022 Dec;
7(2):e2-e4.
PMID: 36566755
No abstract available.
5.
Sharp A, Mudda G, Braehler M, Gesthalter Y
J Bronchology Interv Pulmonol
. 2022 Mar;
29(2):109-114.
PMID: 35318987
Background: Anesthesia and analgesia for thoracic procedures, specifically pleuroscopy, present unique challenges given the spectrum of underlying pulmonary disease and susceptibility to respiratory complications. This study describes efforts to reduce...
6.
Glazik R, Moore H, Kennedy D, Bower H, Rohan H, Sharp A, et al.
PLoS One
. 2021 Nov;
16(11):e0260041.
PMID: 34818367
Background: In response to the COVID-19 pandemic, governments have implemented a range of non-pharmaceutical interventions (NPIs) and pharmaceutical interventions (PIs) to reduce transmission and minimise morbidity and mortality, whilst maintaining...
7.
Sharp A, Minaji M, Panagiotopoulos N, Reeves R, Charlett A, Pebody R
Influenza Other Respir Viruses
. 2021 Oct;
16(1):125-131.
PMID: 34658161
Respiratory syncytial virus (RSV) is a common seasonal respiratory virus and an important cause of illness among infants, but the burden of RSV disease is not well described among the...
8.
Policy and planning for large epidemics and pandemics - challenges and lessons learned from COVID-19
Sharp A, Jain V, Alimi Y, Bausch D
Curr Opin Infect Dis
. 2021 Aug;
34(5):393-400.
PMID: 34342301
Purpose Of Review: The COVID-19 pandemic is a global catastrophe that has led to untold suffering and death. Many previously identified policy challenges in planning for large epidemics and pandemics...
9.
Sharp A, Muller-Pebody B, Charlett A, Patel B, Gorton R, Lambourne J, et al.
Euro Surveill
. 2021 Feb;
26(8).
PMID: 33632376
Background is an emerging multidrug-resistant fungal pathogen associated with bloodstream, wound and other infections, especially in critically ill patients. carriage is persistent and is difficult to eradicate from the hospital...
10.
Sharp A, Blake A, Backx J, Panunzi I, Barrais R, Nackers F, et al.
PLoS Negl Trop Dis
. 2020 Feb;
14(1):e0007967.
PMID: 32004316
Oral cholera vaccine (OCV) has increasingly been used as an outbreak control measure, but vaccine shortages limit its application. A two-dose OCV campaign targeting residents aged over 1 year was...